Onglyza Risks and Lawsuits

Onglyza, a Type-2 diabetes medication, faces mounting lawsuits in response to patient injuries and an increased risk of death from heart failure. Litigation against the medication is still in its early stages as the U.S. Food and Drug Administration (FDA) continues to collect research data on the associated risks.

Search LawInfo's Onglyza Resources

Ashburn Onglyza Lawyers